Huachuang Securities Maintains "Strong Buy" Rating for CONANT OPTICAL (02276), Raises Target Price to HK$63.63

Stock News
2025/12/18

CONANT OPTICAL (02276) has demonstrated strong performance in the eyewear manufacturing industry, with balanced growth in domestic and international sales. Structural upgrades are expected to drive sustained improvements in profitability. The company has partnered with leading 3C manufacturers to develop smart glasses, indicating promising growth prospects.

Given the accelerated development of the smart glasses supply chain and the company's steady product structure optimization, Huachuang Securities forecasts net profits attributable to shareholders of RMB 560 million, RMB 700 million, and RMB 870 million for 2025-2027, with corresponding P/E ratios of 41x, 33x, and 27x. Based on comparable company valuations, the bank assigns a 2026 P/E of 40x, raising the target price to HK$63.63 while maintaining a "Strong Buy" rating.

Key highlights include: - Strong demand for Quark AI glasses has exceeded expectations, with delivery lead times extended to 45 days on platforms like Tmall, Douyin, and JD.com. Additional production lines have been added to meet holiday season demand. - CONANT OPTICAL is the exclusive lens supplier for Quark AI glasses, with premium pricing for high-index lenses (e.g., 1.60/1.67/1.74 refractive index lenses priced RMB 719/899/1,529 higher than standard lenses). - The company holds a first-mover advantage in the XR sector with high technical barriers, positioning it well for future supply chain advancements.

Core business remains stable, with North American operations recovering. The upcoming Japanese factory, set for completion in Q4, will add 600,000 customized lens units, potentially reducing U.S. tariffs. Further expansion in Thailand will enhance global supply capabilities, supporting steady growth in the core business.

Risks include slower-than-expected smart glasses adoption, domestic channel expansion challenges, and intensifying industry competition.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10